Jane Street Group, LLC Biovie Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Biovie Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 176,236 shares of BIVI stock, worth $488,173. This represents 0.0% of its overall portfolio holdings.

Number of Shares

176,236

Holding current value

$488,173

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$0.4 - $0.56 $70,494 - $98,692	176,236 New	176,236 $70,000
Q1 2023 May 15, 2023	BUY	$4.89 - $10.53 $126,142 - $271,631	25,796 New	25,796 $208,000

Others Institutions Holding BIVI

# of Institutions

Shares Held

4.73M

Call Options Held

17.2K

Put Options Held

27K

Altium Capital Management LP New York, NY

1.98M
Shares

$5.49 Million
0.42% of portfolio
Sabby Management, LLC Upper Saddle River, NJ

733K
Shares

$2.03 Million
19.26% of portfolio
Vanguard Group Inc Valley Forge, PA

568K
Shares

$1.57 Million
0.0% of portfolio
Swisspartners Ltd. Vaduz, N2

294K
Shares

$815,338
2.92% of portfolio
Geode Capital Management, LLC Boston, MA

232K
Shares

$641,687
0.0% of portfolio

View Full List

About BIOVIE INC.

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

More about BIVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account